In our previous meta-analysis, the pooled germline mutation frequencies of hMLH1 and hMSH2 genes were 28.55% (95% CI: 26.04%–31.19%) and 19.41% (95% CI: 15.88%–23.51%) in Amsterdam-criteria positive LS CRC. The gene discussed is MSH2; the disease is colorectal carcinoma.